The W.H.O. announced on Feb. 11 a new name for the disease caused by the current novel coronavirus epidemic: Coronavirus Disease 2019 (COVID-19). As for the virus itself, the International Committee on Taxonomy of Viruses has decided on SARS-CoV-2, which “formally recognizes this virus as a sister to severe acute respiratory syndrome coronaviruses.” #COVID19 and #SARSCoV2 are the common social media signatures we are encouraging people use.

The information on this page is not intended as medical advice or clinician guidance. Please help us be more inclusive of fact-based resources that would add to the quality of this page by sending to: editor@globalbiodefense.com

FEATURED ARTICLES

COVID-19 Tests: How They Work and What’s in Development

COVID-19 Tests: How They Work and What’s in Development

One of the key factors in tackling the spread of COVID-19 across the globe is testing. In South Korea, for example, mass testing has been…

What We Know About ACE Inhibitors, High Blood Pressure and COVID-19

What We Know About ACE Inhibitors, High Blood Pressure and COVID-19

The COVID-19 pandemic has unsurprisingly been associated with a similar epidemic of social media misinformation. But there are also some genuine clinical issues of relevance…

WUSTL Researchers Investigate Transfusion of Antibodies from Recovered Patients’ as COVID-19 Treatment

WUSTL Researchers Investigate Transfusion of Antibodies from Recovered Patients’ as COVID-19 Treatment

With no drugs or vaccines yet approved for COVID-19 and the number of U.S. cases increasing by the thousands every day, doctors are looking to…

Blood Types and Coronavirus: Are People With Blood Group A Really at Higher Risk?

Blood Types and Coronavirus: Are People With Blood Group A Really at Higher Risk?

A recent study from China, which has not been peer reviewed yet, suggests a link between having blood group A and a higher risk of…

FDA Allows Emergency Use of Investigational Convalescent Plasma for Critical COVID-19 Patients

FDA Allows Emergency Use of Investigational Convalescent Plasma for Critical COVID-19 Patients

The FDA is facilitating access to convalescent plasma, antibody-rich blood products that are taken from blood donated by people who have recovered from the COVID-19…

BARDA Collaborates with DiaSorin, Mesa Biotech to Develop COVID-19 Rapid Diagnostics

BARDA Collaborates with DiaSorin, Mesa Biotech to Develop COVID-19 Rapid Diagnostics

The U.S. Department of Health and Human Services (HHS) this week announced additional actions to support the development of a novel coronavirus diagnostics. The Biomedical…

View All Featured News


RESOURCES | LINKS


HEADLINE NEWS

Nothing found.

View All Headline News


RESEARCH HIGHLIGHTS

Persons Evaluated for 2019 Novel Coronavirus — United States, January 2020

CDC Morbidity and Mortality Weekly Report (MMWR) On January 17, CDC and the U.S. Department of Homeland Security’s Customs and Border Protection began health screenings at U.S.…

Bats’ Fierce Immune Systems Drive Viruses To Higher Virulence, Making Them Deadlier in Humans

A new University of California, Berkeley, study finds that bats’ fierce immune response to viruses could drive viruses to replicate faster, so that when they jump to…

Steroids Could Do More Harm Than Good in Treating Coronavirus

Steroids should be avoided in the treatment of the current novel coronavirus, experts have advised. A commentary article published in The Lancet concludes that, based on evidence from previous…

A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin

NOTE: The following paper (.pdf) is undergoing accelerated peer-review. Abstract follows: Since the SARS outbreak 18 years ago, a large number of severe acute respiratory syndrome-related coronaviruses…

Coronavirus and Brexit: UK Must Act Quickly Before Being Shut out of Europe’s Health Protection System

The threat posed by 2019-nCoV and the fragmentation of existing health protection systems caused by Brexit call for urgent assessment of cross Europe cooperation, say Mark Flear…

View All Research Journal Highlights

JOURNAL HUBS

“We call on researchers, journals and funders to ensure that research findings and data relevant to this outbreak are shared rapidly and openly to inform the public health response and help save lives.” – Wellcome Trust

NEJM Novel Coronavirus

JAMA Network 2019-nCoV

The Lancet 2019-nCoV Resource Center

Springer Nature Novel Coronavirus Articles

The BMJ Coronavirus Free Online Resources

Elsevier Novel Coronavirus Information Center

BioRxiv Preprint Server *(Caution: information not yet peer-reviewed)

ASM Journal Network Coronavirus Articles American Society for Microbiology

RSTMH Coronavirus Collection


FUNDING | CONTRACTS | GRANTS


Sign up to receive weekly insights from Global Biodefense


INDUSTRY NEWSWIRE

CEPI to Fund Development of Multiple Candidate Vaccines Against the Novel Coronavirus

CEPI, the Coalition for Epidemic Preparedness Innovations, today announced the initiation of three programmes to develop vaccines against the novel coronavirus, nCoV-2019. The programmes will leverage rapid…

Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus

Inovio Pharmaceuticals, Inc. today announced the Coalition for Epidemic Preparedness Innovations (CEPI) has awarded Inovio a grant of up to $9 million to develop a vaccine against…

Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus

Inovio Pharmaceuticals, Inc. today announced the Coalition for Epidemic Preparedness Innovations (CEPI) has awarded Inovio a grant of up to $9 million to develop a vaccine against…

German Researchers Develop 1st Test for New Coronavirus

Researchers from the German Center for Infection Research (DZIF) at Charité – Universitätsmedizin Berlin have developed a new laboratory assay to detect the novel Chinese coronavirus. The assay protocol has now…

View All Industry Newswires


STATE RESOURCES

Arkansas

Arkansas Department of Health

Arkansas Public Health Laboratory

Kentucky

Kentucky Division of Laboratory Service

State Health Officials Actively Monitoring for 2019 Novel Coronavirus 1/29 DPH

District of Columbia
American Samoa